DailyStocks Stock Article Search

https://www.zacks.com/stock/news/2325086/reasons-to-add-cintas-ctas-stock-to-your-portfolio-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2325086 Aug 21, 2024 - Cintas (CTAS) is set to gain from strength across its businesses, acquired assets and shareholder-friendly policies. 0

https://www.fool.com/investing/2024/08/21/this-rising-biotech-a-fantastic-weight-loss-stock/?source=iedfolrf0000001 Aug 21, 2024 - Its pipeline is one of the best among weight loss-focused biotechs right now. 0

https://www.zacks.com/stock/news/2325020/aeon-biopharma-inc-aeon-may-find-a-bottom-soon-here-s-why-you-should-buy-the-stock-now?cid=CS-ZC-FT-tale_of_the_tape|hammer_chart_pattern_(ta)-2325020 Aug 21, 2024 - AEON Biopharma, Inc. (AEON) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean a trend reversal for the stock in the near term. 0

https://www.zacks.com/stock/news/2324939/are-investors-undervaluing-monarch-casino-resort-mcri-right-now?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_2-2324939 Aug 21, 2024 - Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks. 0

https://www.zacks.com/stock/news/2324941/are-investors-undervaluing-crossamerica-partners-capl-right-now?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_2-2324941 Aug 21, 2024 - Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks. 0

https://www.zacks.com/stock/news/2324938/are-investors-undervaluing-royal-caribbean-cruises-rcl-right-now?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_2-2324938 Aug 21, 2024 - Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks. 0

https://www.zacks.com/stock/news/2324946/are-investors-undervaluing-marubeni-maruy-right-now?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_2-2324946 Aug 21, 2024 - Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks. 0

https://www.zacks.com/stock/news/2324948/are-investors-undervaluing-carriage-services-csv-right-now?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_2-2324948 Aug 21, 2024 - Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks. 0

https://www.zacks.com/stock/news/2324945/are-investors-undervaluing-greif-gef-right-now?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_2-2324945 Aug 21, 2024 - Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks. 0

https://www.zacks.com/stock/news/2325050/reasons-to-retain-thermo-fisher-tmo-in-your-portfolio-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2325050 Aug 21, 2024 - Strategic alliances and impressive product launches bode well for Thermo Fisher (TMO). 0